Author name: admin

This cohort study within the EuCARE project entitled: “In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project”, uses data from 38,585 adult patients hospitalised with SARS-CoV-2 Wild-type, Alpha, Delta, or Omicron infection across 10 centres in 9 countries: Germany, Italy, Kenya, Lithuania, Mexico, Poland, Portugal, […]

On the past 21st of December 2023, Miłosz Parczewski, EuCARE partner from the Pomeranian Medical University in Poland, was appointed National Consultant for Infectious Diseases by Polish Minister of Health. This achievement is an important recognition of Milosz important clinical and research work on Infectious Diseases and specially in Virology. Miłosz Parczewski received the MD

This new study, with the participation of Anders Sönnerborg and Marcus Buggert, was published in the npj Biofilms and Microbiomes journal, part of the prestigious Nature group. The manuscript entitled “Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV”, investigates the influence of the gut

The EuCARE project was highlighted as an article in an important Italian newspaper, within the scope of a piece entitled: “What are the best actions to take in emergency situations” The article includes interventions from EuCARE members: Prof. Giulia Marchetti, Dr. Francesca Incardona, Prof Sara Gandini and Prof. Pietro Lopalco. Prof Giulia Marchetti underlines the

Giulia Marchetti, from the ASST Santi Paolo e Carlo, one of the EuCARE partners, was invited to give a presentation about the “Update on the physiopathological mechanisms of Long-COVID: The role of viral/antigen persistence and links to possible therapeutic strategies” at EMA-Workshop on generating clinical evidence for treatment and prevention options for Long-COVID and Post-acute

This new study, with the participation of Alessandro Cozzi-Lepri from University College of London, was published yesterday in the Vaccines journal. The manuscript “Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV” analyses an observational cohort on the outcomes of COVID-19 mRNA vaccination in People living with HIV in a

Following up on our successful and profitable EuCARE ‘Joint Dialogue on Preparedness’ meeting, we are extremely happy to share with our partners and friends 6 take-home messages: 1. A strong evidence-base is essential for the design of successful and ethically acceptable non pharmacological interventions: epidemiological studies should be run quickly, complemented by other observational and randomised controlled studies,

A new EuCARE publication ‘SARS-CoV-2 trends in Italy, Germany and Portugal and school opening during the period of Omicron variant dominance: a quasi-experimental study’ was published this week in the International Journal of Infectious Diseases . The manuscript analyses the impact of schools reopening after summer holidays in 2022 on SARS-CoV-2 dissemination in Italy, Germany

We are so proud to share that our partner Marcus Buggert was awarded the prestigious Anders Jahre award for Medical Research!! Marcus Buggert is an Assistant Professor at the Karolinska Institutet and he got the price for his studies on HIV and SARS-CoV-2 Cellular Mediated Immunity, which are used in the EuCARE project. Congratulations to Marcus Buggert and also

The protocol of the EuCARE-hospitalised cohort study was published on 16th of October by EuCARE partners of Workpackages 2, 3 and 5. This study, which is currently ongoing, follows up hospitalized adult patients with confirmed SARS-CoV-2 infection. The main aim of the study is to gather clinical and laboratory variables from around 35,000 patients. The